126 results
Page 2 of 7
6-K
EX-99.1
vn8ffu6e95ob gcex
30 Jun 22
Statement of Executive Compensation
11:16am
6-K
EX-99.3
317pc
21 Dec 21
51-102F3 Material Change Report
5:28pm
6-K
EX-99.1
79z02l8m3pbhomntk
30 Nov 21
Condensed Consolidated Interim Financial Statements
1:50pm
6-K
EX-99.2
rjdj0n8y78cwkztrn5t9
30 Nov 21
Condensed Consolidated Interim Financial Statements
1:50pm
6-K
EX-99.1
o5uzjl g88
18 Nov 21
Notice of Annual General and Special Meeting of Shareholders
10:36am
6-K
EX-99.2
f2fy0u9xc 9oc
31 Aug 21
Condensed Consolidated Interim Financial Statements
1:45pm
6-K
EX-99.1
0mrefwrzmxha
31 Aug 21
Condensed Consolidated Interim Financial Statements
1:45pm
6-K
EX-99.2
psy574l5
13 Aug 21
51-102F3 Material Change Report
12:00am
6-K
EX-99.2
an6styzd6shy
13 Aug 21
RepliCel CEO Provides Corporate Update
12:00am
6-K
EX-99.1
d0id72i mfst
1 Jun 21
Condensed Consolidated Interim Financial Statements
3:57pm
6-K
EX-99.2
4uo0pj
1 Jun 21
Condensed Consolidated Interim Financial Statements
3:57pm
20-F/A
134icgp
31 Mar 21
Annual report (foreign) (amended)
12:00am
6-K
EX-99.1
nk4lk3n6w
3 Feb 21
RepliCel and MainPointe Pharmaceuticals Sign Strategic Investment and Collaboration Agreement
12:03pm
6-K
EX-99.3
9ivz uh7w
3 Feb 21
RepliCel and MainPointe Pharmaceuticals Sign Strategic Investment and Collaboration Agreement
12:03pm
6-K
EX-99.2
97rr v9w47rv
3 Feb 21
RepliCel and MainPointe Pharmaceuticals Sign Strategic Investment and Collaboration Agreement
12:03pm
6-K
EX-99.4
umls3v1
3 Feb 21
RepliCel and MainPointe Pharmaceuticals Sign Strategic Investment and Collaboration Agreement
12:03pm